Mirum Pharmaceuticals Inc
MIRM
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.6B
Close$
$27.50
69.2% downside
Current Fair Value
69.2% downsideOvervalued by 69.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.60 Billion |
|---|---|
| Enterprise Value | $6.03 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.49 |
| Outstanding Shares | 63,374,183 |
Return
| Return on Equity | 8253.76% |
|---|---|
| Return on Assets | -82.32% |
| Return on Invested Capital | -98.09% |
Valuation & Multiples
| P/E Ratio | -6.31 |
|---|---|
| PEG | -0.6 |
| Price to Sales | 12.77 |
| Price to Book Ratio | -89.36 |
| Enterprise Value to Revenue | 13.16 |
| Enterprise Value to EBIT | -7.48 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | -72.97 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.74
Average shareholder expectationRevenue Estimate
$166.33 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.53
Average shareholder expectationRevenue Estimate
$178.06 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4855▲ 41.07% |
|---|---|
| Total Calls | 100,100▼ 53.46% |
| Total Puts | 48,600▲ 201.86% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 113.43%▼ 2.54% |
|---|---|
| Total Invested | $8.42B▲ 33.72% |
| Investors Holding | 338▲ 20.00% |
ESG Score
No data